medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Number 2

<< Back Next >>

Ann Hepatol 2011; 10 (2)

Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community

Asabamaka OC, Ogbera AO, Balogun BO

Language: English
References: 22
Page: 119-124
PDF size: 65.47 Kb.


ABSTRACT

Background. Liver disease continues to be a major cause of morbidity and mortality in sub-Saharan Africa, including Nigeria, due to the high endemicity of viral hepatitis B. However non-alcoholic fatty liver disease may be an important contributory factor. The impact of fatty liver disease in our region has not been evaluated. AIM. To determine the prevalence of non-alcoholic fatty liver disease (NAFLD) among a population of diabetic (DM) subjects attending the endocrine clinic of LASUTH compared with non-diabetic subjects; ascertain other contributing factors and compare the occurrence of the metabolic syndrome in subjects with and without NAFLD. Methodology. Consecutive patients who satisfy the study criteria were enrolled. An investigator- administered questionnaire was used to determine symptoms of liver disease, followed by physical examination to obtain anthropometric indices as well as signs of liver disease. Abdominal scan was performed to determine radiologic evidence of fatty liver and fasting blood samples were collected from for the measurement of fasting lipid profile, glucose, liver biochemistry and serology for hepatitis B and C markers. Results. One hundred and fifty subjects, mean age 56years (standard deviation = 9, range 20-80 yr) and gender ratio (F: M) of 83:67(55%:45%), were recruited. 106 were diabetics and 44 non-diabetics. The overall prevalence of NAFLD amongst all study subjects was 8.7%. The prevalence rate of NAFLD was higher in the DM cases than in the Control subjects but this difference was not statistically significant (9.5 vs. 4.5%, p = 0.2). Only one of the subjects with fatty liver disease had elevated transaminase levels (steatohepatitis) and also had type 2 DM. Central obesity as measured by waist circumference (WC) and SGPT levels were significantly higher in people with fatty liver. The mean body mass index (BMI) of diabetic and non-diabetic patients was similar (31 vs. 30 kg/m2). The prevalence of the metabolic syndrome was higher in the subjects with NAFLD than in those without fatty liver disease but this difference was not statistically significant (p = 0.8). Conclusion. Non-alcoholic fatty liver disease is present in Africa but is less than what one would expect based on American and European studies.


REFERENCES

  1. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 2009; 49: 791-801.

  2. Sears D. Fatty liver: Available at WWW.Medscape.com/ view article/588890 accessed 8/7/2010.

  3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16): 1640-5.

  4. Deedwania PC, Gupta R: Management issues in the metabolic syndrome. J Assoc Physicians India 2006; 54: 797-810.

  5. Ogbera A. Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome 2010; 2: 1doi:10.1186/1758-5996-2-1.

  6. Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr 2009; 49(4): 442-9.

  7. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor K D, Feldstein A, Angulo P. The natural history of NAFLD; a population- based cohort study. Gastroenterology 2005; 129: 113-21.

  8. Hui JM, Hodge A, Farell GC, Kench JG, Kriketos A, George J. Beyond Insulin resistance in NASH; TNF alpha or adiponectin. Hepatology 2004; 40: 46-54.

  9. Younossi ZM. Current management of NAFLD and NASH. Alim Pharm & Therapeutics 2008; 28(1): 2-12.

  10. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102(12): 2716-7.

  11. Lesi OA, Soyebi KS, Eboh CN Fatty liver in a cohort of HIV positive Africans on HAART. J Nat Med Assoc 2009; 101: 151-5.

  12. Schumann G, Bonora R, Ceriotti F, Férard G, Ferrero CA, Franck PF, Siekmann L, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase. Clin Chem Lab Med 2002; 40(7): 725-33.

  13. Abell LL, Levy BB, Brodie BB, Kendall FE. Simplified methods for the estimation of the total cholesterol in serum and demonstration of specificity. J Biol Chem 1952; 195: 357-66.

  14. Lopez-Virella ML: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-90.

  15. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-582.

  16. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra centrifuge. Clin Chem 1972; 18: 499-502.

  17. Corrao G, Bagnardi V, Zambon A, La Vecchia MC. A metaanalysis of alcohol consumption and the risk of 15 diseases Preventive Medicine Volume 2004; 38(5): 613-9.

  18. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO/IDF Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Org; 2006.

  19. Ivashkin V, Drapkina O, Ashikhmin Y. Prevalence and risk factors for non alcoholic fatty liver disease in Russian Federation.(abstract 330). J Hepatol 2010; (Supl.).

  20. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Wasada T. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabetic Medicine 2005; 22: 1141–5.

  21. Clinical practice committee AGA. AGA Technical review on NAFLD. Gastroenterology 2002; 123: 1705-25.

  22. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver disease in a general population of Okinawa, Japan. Japan J Med 1988; 27(2): 142-9.




2020     |     www.medigraphic.com